Intraportal FK 506 improves intrahepatic islet allograft survival. Read more about Intraportal FK 506 improves intrahepatic islet allograft survival.
Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient. Read more about Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.
Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients. Read more about Efficacy and toxicity of FK 506 for the treatment of resistant rejection in liver transplant patients.
Studies of privileged sites and islet transplantation. Read more about Studies of privileged sites and islet transplantation.
T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies. Read more about T-cell activation and lymphokine production induced by antihuman CD3 monoclonal antibodies.
Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice. Read more about Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.
Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat. Read more about Selective T-cell depletion of recipients in allogeneic small bowel transplantation (SBT) in the rat.
The regulation of T-cell antigen receptor signal transduction function. Read more about The regulation of T-cell antigen receptor signal transduction function.
Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients. Read more about Effect of cyclosporine on the clinical course of HBsAg-positive renal transplant patients.
Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer. Read more about Correction of ADA deficiency in human T lymphocytes using retroviral-mediated gene transfer.
